Vı́ctor Navarro

机构：Hebron University, Universidad de Zaragoza, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology · ORCID：0000-0001-6925-4605

发表论文 151 篇 · 总被引 2648 次 · h-index 28

代表论文

• Impact of prior bendamustine exposure on bispecific antibody outcomes in relapsed/refractory follicular lymphoma (2026 · Blood Advances · 被引 4)
• Allogeneic HCT as consolidation in B-cell lymphomas after exposure to bispecific antibodies: a GETH-TC study (2026 · Blood Advances · 被引 3)
• Endocrine-based strategies after CDK4/6 inhibitors in biomarker-selected subgroup of hormone receptor positive advanced breast cancer: A systematic review and network meta-analysis (2025 · Cancer Treatment Reviews · 被引 3)
• Meeting Report: Herbal and Dietary Supplement Safety Surveillance Summit (2025 · Drug Safety · 被引 2)
• Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell Transplantation (2025 · Cancers · 被引 1)
• Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q (2026 · Blood Advances)